Page last updated: 2024-12-07
18,19-dihydroxycorticosterone
Description
## 18,19-Dihydroxycorticosterone (18,19-DHB)
18,19-Dihydroxycorticosterone (18,19-DHB) is a **steroid hormone** that is a **metabolite of corticosterone**. It is produced in the **adrenal glands** and has been found to be present in various tissues, including the **brain**, **liver**, and **kidneys**.
**Key characteristics of 18,19-DHB:**
* **Structure:** It is a derivative of corticosterone, with hydroxyl groups added at the 18 and 19 positions.
* **Synthesis:** It is formed through the enzymatic oxidation of corticosterone by the enzyme **18-hydroxysteroid dehydrogenase type 1 (18-HSD1)**.
* **Biological activity:** 18,19-DHB has been shown to have **various biological activities**, including:
* **Anti-inflammatory effects:** It has been shown to inhibit the production of inflammatory mediators like prostaglandins and leukotrienes.
* **Neuroprotective effects:** It has been shown to protect neurons from damage induced by oxidative stress and excitotoxicity.
* **Cardiovascular effects:** It has been suggested to have potential benefits for heart health, including lowering blood pressure and reducing inflammation in blood vessels.
* **Metabolic effects:** It may play a role in regulating glucose metabolism and insulin sensitivity.
**Importance for research:**
18,19-DHB is becoming increasingly important for research due to its potential therapeutic applications. Studies are investigating its potential as a:
* **Anti-inflammatory drug:** Its anti-inflammatory properties make it a potential candidate for treating inflammatory diseases like arthritis and inflammatory bowel disease.
* **Neuroprotective agent:** Its neuroprotective effects may make it useful for treating neurodegenerative disorders like Alzheimer's and Parkinson's disease.
* **Cardiovascular drug:** Its potential benefits for heart health make it a promising candidate for the prevention and treatment of cardiovascular diseases.
* **Metabolic modulator:** Its influence on glucose metabolism and insulin sensitivity could be beneficial in managing diabetes and other metabolic disorders.
**Challenges and future directions:**
* **Limited understanding of its mechanisms:** The exact mechanisms of action of 18,19-DHB are not fully understood. Further research is needed to elucidate its precise biological targets and signaling pathways.
* **Development of therapeutic strategies:** The development of therapeutic strategies based on 18,19-DHB requires more research on its pharmacokinetics, pharmacodynamics, and safety.
* **Exploration of its role in human health:** Research is needed to understand the role of 18,19-DHB in human health, including its potential implications for various diseases and conditions.
Overall, 18,19-DHB is a promising steroid hormone with potential therapeutic applications in various fields. Further research is needed to fully understand its biological properties and translate its potential into effective treatments for human diseases.
18,19-dihydroxycorticosterone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 130778 |
MeSH ID | M0147701 |
Synonyms (7)
Synonym |
115288-31-8 |
pregn-4-ene-3,20-dione, 11,18,19,21-tetrahydroxy-, (11beta)- |
18,19-dhco |
18,19-dihydroxycorticosterone |
(8s,9s,10s,11s,13r,14s,17s)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-bis(hydroxymethyl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
11,18,19,21-tetrahydroxypregn-4-ene-3,20-dione |
DTXSID80921668 |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 8 (88.89) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.87
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.87 (24.57) | Research Supply Index | 2.40 (2.92) | Research Growth Index | 5.26 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |